About the Campaign
The Campaign for Patient Access was launched by the American College of Cardiology in December 2009 as a national effort to reverse Medicare physician fee schedule cuts that threatened cardiovascular care. The site provided background on the issue, the ACC's legislative and legal response, resources for patients and practices, a newsroom tracking coverage across the country, and ways for supporters to share their stories and support the campaign.
From the Newsroom
Medicare Meltdown: Access to Health Care in "Critical Condition"
A press release warning that cardiology access was in critical condition due to Medicare payment cuts.
Read more
Cardiology Takes Legal Action Against Medicare
The ACC filed suit against HHS Secretary Kathleen Sebelius over the 2010 Physician Fee Schedule.
Read more
ACC Statement on Health Care Reform
The ACC used the State of the Union address to highlight the need to reverse the Medicare cuts.
Read more
Medicare Patients and Physicians Join Petition Drive
Patients and physicians in Washington, DC joined a petition drive calling on Congress for Medicare reform.
Read moreUnderstanding the Medicare Fee Schedule and Heart Patient Access
Understanding the Medicare Physician Fee Schedule and why it matters for heart patients starts with a distinction: this is a United States payment system, not Australia’s Medicare. The American College of Cardiology launched the Campaign for Patient Access to oppose scheduled reductions to physician payments and defend cardiovascular services. The campaign highlighted policy, legal and legislative routes that could protect appointments, diagnostics and follow-up care.
For Australian readers, US fee decisions do not alter Australian Medicare, Pharmaceutical Benefits Scheme or private-insurance entitlements. They offer a useful case study in how payment pressure travels through a health system. Similar pressures—rising operating costs, workforce constraints and stretched public budgets—shape cardiology access in Sydney, Melbourne and regional communities, even where the local funding rules differ.
A US policy with consequences at the bedside
The Medicare Physician Fee Schedule determines what Medicare pays clinicians for covered outpatient and ambulatory services. It is not the patient’s bill: deductibles, coinsurance and supplementary insurance can still apply. When the schedule reduces the payment for a service, a practice may receive less while staffing, equipment, consumables and premises costs continue to rise.
A side-by-side view clarifies the differences between the two Medicare systems:
| Issue | United States Medicare | Australian Medicare |
|---|---|---|
| Payment schedule | Medicare Physician Fee Schedule for covered professional services | Medicare Benefits Schedule for subsidised medical services |
| Main users | Primarily people aged 65 and over, disabled people and others meeting eligibility rules | Eligible Australian residents, with Medicare generally serving as the foundation of health funding |
| Payment calculation | Relative Value Units, an annual conversion factor and other adjustments | Service-specific rebates or benefit amounts, influenced by government policy |
| Patient contribution | Deductibles, coinsurance and possible supplementary-insurance charges | The Medicare amount plus possible out-of-pocket payments or an insurance gap |
| Policy concern in the campaign | Falling professional payments potentially weakening cardiovascular capacity | Budgets, indexation and workforce distribution affecting access and affordability |
That squeeze can affect more than profit. A cardiology practice may hold appointments open, reduce administrative support, limit same-day tests, decline new Medicare patients or stop offering a service at one site. The impact varies by specialty, location and service setting, so an overall percentage cut does not tell the full story for every heart-care team.
How the fee schedule actually works
Payments begin with Relative Value Units, or RVUs. These attach weights to a service’s physician work, practice overhead and clinical resources. Medicare converts those weights into dollars through an annual conversion factor, then applies geographic and quality adjustments. A simplified calculation is RVUs multiplied by the conversion factor and relevant adjustments.
Budget neutrality is central. If Medicare’s expected spending for physician services exceeds the target, the conversion factor is adjusted to constrain growth. Clinicians may have no direct control over that decision, even though they know exactly how much a visit, echocardiogram or catheter-based procedure costs to deliver.
Congress sets the legal framework, while the Centers for Medicare and Medicaid Services implements it through an annual proposed and final rule. Comments, new evidence and revised calculations can change a rule before it takes effect. Congress can also alter the underlying statute or use broader budget measures, which is why advocacy focuses on both agencies and lawmakers.
Why cardiology access can tighten
Cardiology relies on connected services rather than a single consultation. An ECG may lead to echocardiography; abnormal rhythms may require electrophysiology; coronary disease may need catheter-based imaging or intervention. Stable heart failure and hypertension depend on repeated medication review, often coordinated between a cardiologist, general practitioner, pharmacist and nurse.
Lower professional payments can therefore appear in the patient journey as a longer wait, fewer follow-up slots, reduced testing capacity or pressure to move services between hospital and community settings. A patient who already travels from a regional town may face an additional barrier, while a metropolitan patient may encounter fewer available appointments.
These outcomes are not inevitable. Stable funding, sensible payment distribution and adequate hospital capacity can preserve access. The campaign’s message was that patients need reliable access to timely diagnosis and treatment, since delayed cardiovascular care can turn a manageable condition into a medical emergency.
What this means for Australian patients
Australia’s system has different names and institutions. Medicare Australia pays clinicians through the Medicare Benefits Schedule, with many services supplied in public hospitals, private hospital settings and community practices. The Pharmaceutical Benefits Scheme subsidises many medicines, while private insurance and out-of-pocket payments can cover gaps. Decisions about public-hospital funding and specialist capacity therefore sit across multiple levels of government.
Everyday Australian habits already connect these parts of care: blood-pressure medicines are often obtained from a community pharmacy, repeat scripts and dose changes require review, and telehealth can reduce travel for stable patients. In cities, patients may choose among large cardiology practices and imaging networks. In regional areas, the nearest echocardiography or catheter laboratory can still be hours away, and specialist shortages make continuity more fragile.
Federal law, including the National Health Act 2023, provides the framework for Medicare and the MBS, while state and territory governments operate public hospitals and regulate many facilities. Primary Health Networks help coordinate local pathways. These Australian arrangements are not controlled by the US campaign, but they show why a payment change should be assessed through waiting times, access and clinical outcomes rather than a budget line alone.
Practical choices for patients and practices
Patients and clinicians can make the policy debate concrete by focusing on access, delays and affordability. Useful questions for an Australian appointment include:
For patients and carers
- Is the clinic bulk-billing, and is it accepting new Medicare patients?
- What will Medicare cover, and what remains a gap or out-of-pocket expense?
- Can the general practitioner manage medicines while the specialist wait continues?
- Are ECGs, echocardiograms and follow-ups available in hospital, community or telehealth settings?
- Which PBS subsidy applies, and are repeat prescriptions needed before review?
For practices, pharmacists and advocates
- Track time to first appointment, cancellations and the travel burden on patients.
- Record where echocardiography, rhythm monitoring and procedures are referred.
- Quantify wages, rent, consumables and shortfalls after Medicare and insurance payments.
- Share timely examples with the relevant professional body, Primary Health Network or patient group.
- Report effects on access and continuity of care, not simply lost revenue.
A patient story can show what an average figure hides: a cancelled follow-up, a longer drive, uncertainty about medication costs or anxiety while waiting for a test. A practice can show which fixed costs and service lines are vulnerable. For the US campaign, such evidence helps explain the effect of a proposed fee cut to Congress and CMS; in Australia, it can support submissions on MBS and hospital policy.
Legal and legislative routes to protect access
US policy can be challenged through several routes. Congress can amend Medicare law or delay a scheduled reduction. CMS must publish proposed rules, receive public comment and explain the final calculation. Federal courts may review agency decisions under the Administrative Procedure Act, although a court does not automatically replace an agency’s policy judgment. MedPAC provides independent advice to Congress.
The Campaign for Patient Access uses these avenues to press for payment stability and protection of cardiovascular capacity. Advocacy can include written comments, meetings with lawmakers, coalition work, public reporting and patient testimony. The strongest cases connect a clinical consequence—longer waits or reduced service availability—to a specific payment decision and a workable remedy.
Australian readers can apply the same discipline locally: submit evidence about cardiology waits to federal consultations on Medicare and medicines, raise hospital outpatient and rural-service issues with state health ministers, and work through Primary Health Networks. Federal MPs, Senate committees and state members all influence different parts of access, so evidence should be addressed to the decision-maker that controls the relevant funding.
Keep cardiovascular care within reach
Personal experience has policy value. Patients in the United States can give the Campaign for Patient Access a concise account of delayed appointments, travel, treatment choices or financial pressure, while clinicians can document how a proposed fee reduction would affect staffing and service lines. Australians can contribute equivalent examples through their cardiology groups, Primary Health Networks, private-insurer forums and submissions to government consultations.
Immediate action should remain clinical: seek urgent care for new chest pain, severe breathlessness, fainting or other warning signs rather than waiting for an advocacy response, and ask a general practitioner or pharmacist to review medicines and referral options. For the wider campaign, support calls for stable cardiovascular funding, publish accurate personal stories and send them to the relevant decision-maker. Sound payment policy matters because behind every fee adjustment is a person who needs a timely diagnosis, a functioning treatment plan and access to follow-up care.
Campaign for Patient Access